UniProt ID | ITB3_HUMAN | |
---|---|---|
UniProt AC | P05106 | |
Protein Name | Integrin beta-3 | |
Gene Name | ITGB3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 788 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein . Cell projection, lamellipodium membrane . Cell junction, focal adhesion . |
|
Protein Description | Integrin alpha-V/beta-3 (ITGAV:ITGB3) is a receptor for cytotactin, fibronectin, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin, vitronectin and von Willebrand factor. Integrin alpha-IIb/beta-3 (ITGA2B:ITGB3) is a receptor for fibronectin, fibrinogen, plasminogen, prothrombin, thrombospondin and vitronectin. Integrins alpha-IIb/beta-3 and alpha-V/beta-3 recognize the sequence R-G-D in a wide array of ligands. Integrin alpha-IIb/beta-3 recognizes the sequence H-H-L-G-G-G-A-K-Q-A-G-D-V in fibrinogen gamma chain. Following activation integrin alpha-IIb/beta-3 brings about platelet/platelet interaction through binding of soluble fibrinogen. This step leads to rapid platelet aggregation which physically plugs ruptured endothelial surface. Fibrinogen binding enhances SELP expression in activated platelets (By similarity). ITGAV:ITGB3 binds to fractalkine (CX3CL1) and acts as its coreceptor in CX3CR1-dependent fractalkine signaling. [PubMed: 23125415] | |
Protein Sequence | MRARPRPRPLWATVLALGALAGVGVGGPNICTTRGVSSCQQCLAVSPMCAWCSDEALPLGSPRCDLKENLLKDNCAPESIEFPVSEARVLEDRPLSDKGSGDSSQVTQVSPQRIALRLRPDDSKNFSIQVRQVEDYPVDIYYLMDLSYSMKDDLWSIQNLGTKLATQMRKLTSNLRIGFGAFVDKPVSPYMYISPPEALENPCYDMKTTCLPMFGYKHVLTLTDQVTRFNEEVKKQSVSRNRDAPEGGFDAIMQATVCDEKIGWRNDASHLLVFTTDAKTHIALDGRLAGIVQPNDGQCHVGSDNHYSASTTMDYPSLGLMTEKLSQKNINLIFAVTENVVNLYQNYSELIPGTTVGVLSMDSSNVLQLIVDAYGKIRSKVELEVRDLPEELSLSFNATCLNNEVIPGLKSCMGLKIGDTVSFSIEAKVRGCPQEKEKSFTIKPVGFKDSLIVQVTFDCDCACQAQAEPNSHRCNNGNGTFECGVCRCGPGWLGSQCECSEEDYRPSQQDECSPREGQPVCSQRGECLCGQCVCHSSDFGKITGKYCECDDFSCVRYKGEMCSGHGQCSCGDCLCDSDWTGYYCNCTTRTDTCMSSNGLLCSGRGKCECGSCVCIQPGSYGDTCEKCPTCPDACTFKKECVECKKFDRGALHDENTCNRYCRDEIESVKELKDTGKDAVNCTYKNEDDCVVRFQYYEDSSGKSILYVVEEPECPKGPDILVVLLSVMGAILLIGLAALLIWKLLITIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
61 | Phosphorylation | DEALPLGSPRCDLKE CCCCCCCCCCCCCCC | 19.49 | 20562096 | |
67 | Ubiquitination | GSPRCDLKENLLKDN CCCCCCCCCCCCCCC | 31.16 | 29967540 | |
100 | Phosphorylation | RPLSDKGSGDSSQVT CCCCCCCCCCHHHCE | 45.21 | 28270605 | |
103 | Phosphorylation | SDKGSGDSSQVTQVS CCCCCCCHHHCEEEC | 26.62 | 28270605 | |
104 | Phosphorylation | DKGSGDSSQVTQVSP CCCCCCHHHCEEECC | 33.15 | 28270605 | |
107 | Phosphorylation | SGDSSQVTQVSPQRI CCCHHHCEEECCCEE | 18.67 | 28270605 | |
110 | Phosphorylation | SSQVTQVSPQRIALR HHHCEEECCCEEEEE | 12.90 | 28787133 | |
125 | N-linked_Glycosylation | LRPDDSKNFSIQVRQ ECCCCCCCEEEEEEE | 39.59 | 16263699 | |
127 | Phosphorylation | PDDSKNFSIQVRQVE CCCCCCEEEEEEEEC | 22.85 | 27794612 | |
208 | Phosphorylation | NPCYDMKTTCLPMFG CCCCCCCCCEECCCC | 18.99 | - | |
221 | Phosphorylation | FGYKHVLTLTDQVTR CCCCEEEEHHHHHHH | 26.90 | 28060719 | |
223 | Phosphorylation | YKHVLTLTDQVTRFN CCEEEEHHHHHHHCC | 21.10 | 28060719 | |
227 | Phosphorylation | LTLTDQVTRFNEEVK EEHHHHHHHCCHHHH | 24.74 | - | |
346 | N-linked_Glycosylation | NVVNLYQNYSELIPG HHHHHHHHHHHHCCC | 28.83 | 11546839 | |
397 | N-linked_Glycosylation | EELSLSFNATCLNNE CHHEEEEEEEECCCC | 30.85 | 11546839 | |
422 | Phosphorylation | LKIGDTVSFSIEAKV CCCCCEEEEEEEEEE | 18.50 | 28634298 | |
424 | Phosphorylation | IGDTVSFSIEAKVRG CCCEEEEEEEEEECC | 16.41 | 28634298 | |
439 | Phosphorylation | CPQEKEKSFTIKPVG CCCCCCCCEEEECCC | 28.81 | - | |
441 | Phosphorylation | QEKEKSFTIKPVGFK CCCCCCEEEECCCCC | 34.87 | - | |
478 | N-linked_Glycosylation | SHRCNNGNGTFECGV CCCCCCCCCEEECCE | 48.75 | 17660510 | |
585 | N-linked_Glycosylation | DWTGYYCNCTTRTDT CCCCEECCCCCCCCC | 15.28 | 11546839 | |
611 | Phosphorylation | RGKCECGSCVCIQPG CCCEECCCEEEECCC | 18.29 | 28387310 | |
619 | Phosphorylation | CVCIQPGSYGDTCEK EEEECCCCCCCCCCC | 32.40 | 28387310 | |
623 | Phosphorylation | QPGSYGDTCEKCPTC CCCCCCCCCCCCCCC | 20.43 | 28387310 | |
660 | Phosphorylation | DENTCNRYCRDEIES CCCHHHHHCHHHHHH | 4.28 | - | |
667 | Phosphorylation | YCRDEIESVKELKDT HCHHHHHHHHHHHHC | 44.12 | 28060719 | |
669 | Ubiquitination | RDEIESVKELKDTGK HHHHHHHHHHHHCCC | 67.61 | 29967540 | |
680 | N-linked_Glycosylation | DTGKDAVNCTYKNED HCCCCCCCCEECCCC | 17.71 | 11546839 | |
767 | Phosphorylation | RARAKWDTANNPLYK HHHHHHCCCCCHHHH | 30.12 | 29970186 | |
773 | Phosphorylation | DTANNPLYKEATSTF CCCCCHHHHCHHHCC | 14.19 | 11723131 | |
777 | Phosphorylation | NPLYKEATSTFTNIT CHHHHCHHHCCCCCE | 29.41 | 29255136 | |
778 | O-linked_Glycosylation | PLYKEATSTFTNITY HHHHCHHHCCCCCEE | 28.68 | 22530207 | |
778 | Phosphorylation | PLYKEATSTFTNITY HHHHCHHHCCCCCEE | 28.68 | 29255136 | |
779 | Phosphorylation | LYKEATSTFTNITYR HHHCHHHCCCCCEEC | 30.08 | 29255136 | |
781 | Phosphorylation | KEATSTFTNITYRGT HCHHHCCCCCEECCC | 26.29 | 29255136 | |
784 | O-linked_Glycosylation | TSTFTNITYRGT--- HHCCCCCEECCC--- | 14.83 | 22530201 | |
784 | Phosphorylation | TSTFTNITYRGT--- HHCCCCCEECCC--- | 14.83 | 28060719 | |
785 | Phosphorylation | STFTNITYRGT---- HCCCCCEECCC---- | 11.84 | 11546839 | |
788 | Phosphorylation | TNITYRGT------- CCCEECCC------- | 26.83 | 28857561 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
773 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
773 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
777 | T | Phosphorylation | Kinase | PDK1 | Q15118 | GPS |
777 | T | Phosphorylation | Kinase | PDPK1 | O15530 | PhosphoELM |
779 | T | Phosphorylation | Kinase | AKT1 | P31749 | Uniprot |
779 | T | Phosphorylation | Kinase | PDK1 | Q15118 | GPS |
779 | T | Phosphorylation | Kinase | PDK1 | O15530 | PSP |
779 | T | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
785 | Y | Phosphorylation | Kinase | SYK | P43405 | GPS |
785 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
785 | Y | Phosphorylation | Kinase | SYK | Q15046 | PhosphoELM |
785 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
779 | T | Phosphorylation |
| 10896934 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ITB3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00083 | Allograft rejection | |||||
H00226 | Glanzmann thrombasthenia | |||||
OMIM Disease | ||||||
273800 | Glanzmann thrombasthenia (GT) | |||||
187800 | Bleeding disorder, platelet-type 16 (BDPLT16) | |||||
Kegg Drug | ||||||
D01029 | Tirofiban hydrochloride (USAN); Tirofiban hydrochloride hydrate; Aggrastat (TN) | |||||
D02778 | Abciximab (genetical recombination) (JAN); Abciximab (USAN/INN); Reopro (TN) | |||||
D03497 | Cilengitide (USAN/INN) | |||||
D03971 | Elarofiban (USAN) | |||||
D04659 | Lamifiban (USAN/INN) | |||||
D04660 | Lamifiban hydrochloride (USAN) | |||||
D04785 | Lotrafiban hydrochloride (USAN) | |||||
D05267 | Orbofiban acetate (USAN) | |||||
D05772 | Roxifiban acetate (USAN) | |||||
D05834 | Sibrafiban (USAN/INN) | |||||
D06335 | Xemilofiban hydrochloride (USAN) | |||||
D06649 | Tadocizumab (USAN) | |||||
D06888 | Eptifibatide (INN); Integrilin (TN) | |||||
D08607 | Tirofiban (INN); Agrastat (TN) | |||||
D09342 | Etaracizumab (USAN/INN); Abegrin (TN) | |||||
D09903 | Fluciclatide F 18 (USAN/INN) | |||||
D09929 | Maraciclatide (USAN/INN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-680, AND MASSSPECTROMETRY. | |
"Elucidation of N-glycosylation sites on human platelet proteins: aglycoproteomic approach."; Lewandrowski U., Moebius J., Walter U., Sickmann A.; Mol. Cell. Proteomics 5:226-233(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-125, AND MASSSPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-125, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Threonine phosphorylation of the beta 3 integrin cytoplasmic tail, ata site recognized by PDK1 and Akt/PKB in vitro, regulates Shcbinding."; Kirk R.I., Sanderson M.R., Lerea K.M.; J. Biol. Chem. 275:30901-30906(2000). Cited for: PHOSPHORYLATION AT THR-779. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-773, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-773 AND TYR-785, ANDMASS SPECTROMETRY. | |
"Outside-in integrin signal transduction. Alpha IIb beta 3-(GP IIbIIIa) tyrosine phosphorylation induced by platelet aggregation."; Law D.A., Nannizzi-Alaimo L., Phillips D.R.; J. Biol. Chem. 271:10811-10815(1996). Cited for: PHOSPHORYLATION AT TYR-773 AND TYR-785 (ISOFORM BETA-3A). |